Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

eMed vs T2D.com

eMed
Graded #399

Higher grade

vs+4.399999999999999
T2D.com
Graded #475

Lower grade

The verdict

eMed takes it — 57.4/100 to 53/100.

eMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMed is a digital health platform best known for at-home diagnostics that now runs a clinician-supported GLP-1 weight management program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueeMed +16
45
29
Dose & formulationT2D.com +24
40
64
Clinical oversighteMed +14
83
69
Labs & monitoringeMed +13
65
52
FulfillmenteMed +4
62
58
Contract termsEven
55
55
eMed · left barT2D.com · right bar

The numbers

MetriceMedT2D.com
WeighScore57.4/10053/100
GradeCC
Scorecard rank#399#475
SemaglutideNot disclosed$999/mo (starting dose, compounded)
TirzepatideNot disclosed$999/mo (starting dose, compounded)
CoverageCoverage not published1 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
eMed

Graded #399 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Where it loses points

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers
T2D.com

Graded #475 · C

Strengths

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Where it loses points

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard